SEC Filing: Aspire Biopharma Holdings, Inc. (ASBP, ASBPW) Reports An amendment to its governing corporate documents

Aspire Biopharma Holdings, Inc. (ASBP, ASBPW) filed a Form 8-K with the U.S. Securities and Exchange Commission disclosing an amendment to its governing corporate documents, according to the filing dated 2026-09-09.

The 8-K is the form the SEC requires public companies to use to announce major events that shareholders should know about on a current basis, rather than waiting for the next quarterly or annual report.

The filing is publicly available through the SEC's EDGAR system, which maintains disclosure records for all reporting companies.